Abstract: The present invention provides heterocyclic compounds of formula (I), which are therapeutically useful as CBP/EP300 inhibitors. These compounds are useful in the treatment and/or prevention of diseases or disorders mediated by CBP and/or EP300 in an individual. The present invention also provides preparation of the compounds and pharmaceutical compositions comprising at least one of the compounds of formula (I) or a pharmaceutically acceptable salt, or a stereoisomer or a tautomer, an N-oxide or an ester thereof.
| # | Name | Date |
|---|---|---|
| 1 | 202347026201.pdf | 2023-04-07 |
| 2 | 202347026201-STATEMENT OF UNDERTAKING (FORM 3) [07-04-2023(online)].pdf | 2023-04-07 |
| 3 | 202347026201-FORM 1 [07-04-2023(online)].pdf | 2023-04-07 |
| 4 | 202347026201-DECLARATION OF INVENTORSHIP (FORM 5) [07-04-2023(online)].pdf | 2023-04-07 |
| 5 | 202347026201-COMPLETE SPECIFICATION [07-04-2023(online)].pdf | 2023-04-07 |
| 6 | 202347026201-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [07-04-2023(online)].pdf | 2023-04-07 |
| 7 | 202347026201-Proof of Right [07-10-2023(online)].pdf | 2023-10-07 |
| 8 | 202347026201-PETITION UNDER RULE 137 [08-12-2023(online)].pdf | 2023-12-08 |
| 9 | 202347026201-FORM 3 [08-12-2023(online)].pdf | 2023-12-08 |
| 10 | 202347026201-FORM 18 [05-09-2024(online)].pdf | 2024-09-05 |